About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker CLLS

Latest patent grants
GrantedPatentOwnerTypeSource
Oct 27, 202612774451
Methods for improving functionality in NK cell by gene inactivation u…
CLLS
Cellectis S.A.
utilityGoogle Patents ↗
Oct 6, 202612753220
Mesothelin specific chimeric antigen receptors (CAR) for solid tumors…
CLLS
Cellectis S.A.
utilityGoogle Patents ↗
Jul 14, 202612680076
Methods for engineering allogeneic and highly active T cell for immun…
CLLS
Cellectis S.A.
utilityGoogle Patents ↗
Jun 16, 202612655451
TAL-effector nuclease (TALEN)-modified allogenic cells suitable for t…
CLLS
Cellectis S.A.
utilityGoogle Patents ↗
May 5, 202612618048
Dual CAR-T cells
CLLS
Cellectis S.A.
utilityGoogle Patents ↗
Mar 17, 202612577581
Use of pre T alpha or functional variant thereof for expanding TCR al…
CLLS
Cellectis S.A.
utilityGoogle Patents ↗
Jan 27, 202612534744
Methods to genetically modify cells for delivery of therapeutic prote…
CLLS
Cellectis S.A.
utilityGoogle Patents ↗
Aug 19, 202512391933
Targeted gene insertion for improved immune cells therapy
CLLS
Cellectis S.A.
utilityGoogle Patents ↗
Jul 22, 202512365733
Method for improving production of car T cells
CLLS
Cellectis S.A.
utilityGoogle Patents ↗
Mar 18, 202512252699
Method for generating t-cells compatible for allogenic transplantation
CLLS
Cellectis S.A.
utilityGoogle Patents ↗
Feb 11, 202512221478
Targeted gene integration of CRS inhibitor genes for improved immune…
CLLS
Cellectis S.A.
utilityGoogle Patents ↗
Jan 28, 202512209125
Targeted gene integration of NK inhibitors genes for improved immune…
CLLS
Cellectis S.A.
utilityGoogle Patents ↗
Nov 19, 202412144825
Cellular immunotherapy for repetitive administration
CLLS
Cellectis S.A.
utilityGoogle Patents ↗
Nov 5, 202412133867
Universal anti-CD22 chimeric antigen receptor engineered immune cells
CLLS
Cellectis S.A.
utilityGoogle Patents ↗

14 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 10:10 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances